Legend Biotech (LEGN) Inventory Average (2020 - 2026)

Legend Biotech (LEGN) has reported Inventory Average for 7 consecutive years, with $34.6 million the latest figure, recorded in Q1 2026.

• Quarterly Inventory Average rose 26.02% year-over-year to $34.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $34.6 million (up 26.02% YoY) and the FY2025 annual result came in at $28.0 million, up 29.0% from the prior year.
• Inventory Average advanced to $34.6 million in Q1 2026 per LEGN's latest filing, from $30.6 million in the prior quarter.
• Over the last five years, Inventory Average for LEGN reached as high as $34.6 million in Q1 2026 and fell as low as $2.3 million in Q1 2022.
• A 5-year average of $21.9 million and a median of $21.0 million in 2024 frame the typical range for Inventory Average.
• Annual changes were most pronounced in 2023 — Inventory Average surged 385.14% — and 2026, when it rose 26.02%.
• Year by year, Inventory Average stood at $2.3 million in 2022, then soared by 706.35% to $18.7 million in 2023, then climbed by 26.71% to $23.7 million in 2024, then advanced by 28.95% to $30.6 million in 2025, then climbed by 12.94% to $34.6 million in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $34.6 million, $30.6 million, and $32.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.